Trending/large
Study Shows Crohn’s Disease Patients Benefit From Infliximab Plus Azathioprine
The use of infliximab (IFX) plus azathioprine (AZA) and infliximab monotherapy increase the likelihood of patients achieving long-term steroid-free clinical remission in patients with moderate…
June 13, 2010
Special Topics
Sign up
Mayo Clinic Connect
An online patient support community